0001562180-22-000352.txt : 20220107 0001562180-22-000352.hdr.sgml : 20220107 20220107211711 ACCESSION NUMBER: 0001562180-22-000352 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220106 FILED AS OF DATE: 20220107 DATE AS OF CHANGE: 20220107 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stock Elyse CENTRAL INDEX KEY: 0001785732 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38080 FILM NUMBER: 22519447 BUSINESS ADDRESS: BUSINESS PHONE: (203) 404-0410 MAIL ADDRESS: STREET 1: 215 CHURCH STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Biohaven Pharmaceutical Holding Co Ltd. CENTRAL INDEX KEY: 0001689813 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: D8 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 CHURCH STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 BUSINESS PHONE: 203-404-0410 MAIL ADDRESS: STREET 1: 215 CHURCH STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2022-01-06 false 0001689813 Biohaven Pharmaceutical Holding Co Ltd. BHVN 0001785732 Stock Elyse C/O BIOHAVEN PHARMACEUTICALS, INC. 215 CHURCH STREET NEW HAVEN CT 06510 false true false false Chief Medical Officer Common Shares 2022-01-06 4 M false 3750.00 0.00 A 11217.00 D Common Shares 2022-01-06 4 F false 1838.00 123.86 D 9379.00 D Common Shares 2022-01-06 4 M false 1250.00 0.00 A 3437.00 I By Spouse Common Shares 2022-01-07 4 M false 3250.00 0.00 A 12629.00 D Common Shares 2022-01-07 4 F false 1539.00 128.87 D 11090.00 D Common Shares 2022-01-07 4 M false 1000.00 0.00 A 4437.00 I By Spouse Restricted Share Unit Award 2022-01-06 4 M false 3750.00 0.00 D Common Shares 3750.00 7500.00 D Restricted Share Unit Award 2022-01-06 4 M false 1250.00 0.00 D Common Shares 1250.00 2500.00 I By Spouse Employee Stock Option (right to buy) 128.87 2022-01-07 4 M false 26000.00 0.00 A 2032-01-07 Common Shares 26000.00 26000.00 D Restricted Share Unit Award 2022-01-07 4 A false 13000.00 0.00 A Common Shares 13000.00 13000.00 D Restricted Share Unit Award 2022-01-07 4 M false 3250.00 0.00 D Common Shares 3250.00 9750.00 D Restricted Share Unit Award 2022-01-07 4 A false 4000.00 0.00 A Common Shares 4000.00 4000.00 I By Spouse Restricted Share Unit Award 2022-01-07 4 M false 1000.00 0.00 D Common Shares 1000.00 3000.00 I By Spouse No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted share units. Each restricted share unit represents the contingent right to receive one common share of the Issuer. The reporting person was granted 15,000 restricted share units on January 6, 2021, vesting in four equal installments on January 6, 2021, 2022, 2023 and 2024, subject to the reporting person's continued service with the Issuer at each vesting date. Not applicable. The shares underlying this option vest in four equal installments on January 7, 2022, 2023, 2024 and 2025, subject to the reporting person's continuous service with the Issuer at each vesting date. The reporting person was granted 13,000 restricted share units on January 7, 2022, vesting in four equal installments on January 7, 2022, 2023, 2024 and 2025, subject to the reporting person's continued service with the Issuer at each vesting date. The spouse of the reporting person was granted 4,000 restricted share units on January 7, 2022, vesting in four equal installments on January 7, 2022, 2023, 2024 and 2025, subject to the reporting person's continued service with the Issuer at each vesting date. Exhibit List: Exhibit 24: Power of attorney /s/ George Clark, Attorney-in-Fact 2022-01-07 EX-24 2 estockpoa21.txt POA2021 POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints each of Vlad Coric, Matthew Buten, George Clark and Douglas Gray, or either of them signing singly, and with full power of substitution, the undersigned's true and lawful attorney-in-fact to: (1) prepare, execute in the undersigned's name and on the undersigned's behalf, and submit to the U.S. Securities and Exchange Commission (the "SEC") any documents necessary or appropriate to obtain codes and passwords enabling the undersigned to make electronic filings with the SEC of reports required by Section 16(a) of the Securities Exchange Act of 1934 or any rule or regulation of the SEC; (2) execute for and on behalf of the undersigned Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder; (3) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5, complete and execute any amendment or amendments thereto, and timely file such form with the SEC and any stock exchange or similar authority; and (4) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and transactions in securities issued by Biohaven Pharmaceutical Holding Company Ltd., unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 21st day of December, 2021. /s/ Elyse Stock, M.D. Signature Elyse Stock, M.D. Print Name \\\DC - 57385/2 - #1301253 v1 SC1:4975875.1 SC1:4975875.1